KCM
CRL icon

Kingdon Capital Management’s Charles River Laboratories CRL Stock Holding History

Kingdon Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-75,700
Closed -$14M – 82
2024
Q4 		$14M Buy
75,700
+1,600
+2% +$308K 2.39% 16
2024
Q3 		$14.6M Buy
74,100
+4,300
+6% +$894K 2.14% 17
2024
Q2 		$14.4M Buy
+69,800
New +$15.8M 2.23% 22
2022
Q3 		– Sell
-38,365
Closed -$8.21M – 73
2022
Q2 		$8.21M Sell
38,365
-11,835
-24% -$2.89M 2.19% 21
2022
Q1 		$14.3M Buy
+50,200
New +$15.5M 2.43% 19

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return